Navigation Links
Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
Date:7/18/2013

igo) have a business partnership to provide the hospital investigational pharmacy market a combined inventory management solution.

According to Scott McCreadie, Pharm.D, President of the McCreadie Group, "It is important that Vestigo works with companies such as Grifols to help close the loop on medication storage and security in the IDS market. This combined solution will help the IDS meet their regulatory and drug security needs in a way that is efficient and safe."

Juan M. Cana, General Manager of Grifols' Hospital Division acknowledged the importance Grifols places on the amelioration of IDS management by stating that "today's IDS management is, in many cases, a manually based activity with no technology dedicated to this important area of the hospital pharmacy. IDS faces many challenges each day to support research activities for all research groups and investigators. We believe the time is right to provide a combined solution with technologies that have been specially designed for the IDS to support investigational drug handling, control, and storage, as well as record keeping and drug accountability while increasing IDS efficiency. We think this can be a game changer for IDS activity."

About Grifols

Grifols is a global healthcare company with a 70-year legacy of improving people's health and well-being through the development of life-saving plasma medicines, hospital pharmacy products, and diagnostic technology for clinical use.

As a leading producer of plasma medicines, Grifols has a presence in more than 100 countries and is the world leader in plasma collection, with 150 plasma donation centres across the US. Grifols is committed to increasing patient access to its life-saving plasma medicines through significant manufacturing expansions and the development of new therapeutic applications of plasma proteins. The company is headquartered in Barcelona, S
'/>"/>

SOURCE Grifols
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
2. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
3. Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt
4. Comprehensive Care Corporation Implements Steps to Increase Margins and Sustain Profitability
5. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
6. Talyst Implements Over Four Hundred 340B Programs
7. LABSCO Implements Leading-Edge Technology to Support Growth and Seize Opportunities in the Clinical Laboratory Market
8. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
9. Thoratec Schedules First Quarter Conference Call, Webcast
10. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
11. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... MANCHESTER, N.H. , March 2, 2015 ... leading provider of professional-grade vitamins, supplements, prescription ... today announced a strategic partnership with Anabolic ... products for healthcare professionals. This new partnership ... reach into new licensed healthcare practitioner segments ...
(Date:3/2/2015)... Inc. (NYSE MKT: IG), a New Jersey based specialty generic ... and year ended December 31, 2014. Fourth Quarter ... revenues of $13.7 million in the fourth quarter of 2014, ... , Total revenues of $33.7 million for the year ... same period in 2013 , Total net revenues generated ...
(Date:3/2/2015)... Therapeutics, Inc. (NASDAQ: HALO ) today reported financial results ... 2014. Financial highlights for the fourth quarter include revenues of ... $0.04 per share. This compares to revenues of $12.5 million ... share, for the fourth quarter of 2013. Financial highlights for ... a net loss of $68.4 million, or $0.56 per share. ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
... Conference on Avian,Influenza at France's Pasteur Institute, PARIS, ... of,Novavax Inc.'s pandemic influenza vaccine provided protection,against a ... data presented here today at the Second International,Conference ... show that two 0.6 microgram doses of Novavax's,virus-like ...
... of Rare but Devastating,Condition , LONDON, June 1, ... of Leicester and have today (Friday June 1),announced ... rare but,devastating medical condition that can affect children ... clinicians and scientists from the two,universities have already ...
Cached Medicine Technology:Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5
(Date:3/2/2015)... PA (PRWEB) March 02, 2015 Surgeons ... of the Allegheny Health Network, are exploring ... new software called Visual Info Zonal Reminder (VIZR), to ... Introduced in 2013, Google Glass is a wearable technology ... a smartphone-like hands-free format. Wearers communicate with the Internet ...
(Date:3/2/2015)... UK (PRWEB) March 02, 2015 Market ... research reports worked out by Global Industry Analysts Inc ... Therapy Equipment: Market Research Report . Through 2018, the ... a 6.04% CAGR. The detailed research report suggests a ... for radiation therapy equipment as well as covers the ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 While many ... Title VI of the Civil Rights Act, the unique ... hearing loss are bringing light to the value of ... reveal that nearly 1 in 20 U.S. children have ... 10 in some major cities.(1) Stratus Video Interpreting ...
(Date:3/2/2015)... 02, 2015 Gummy smile reduction ... Gum reshaping can involve one or several procedures to reduce ... gum tissue for a more even gum line. Dr. Farnoosh ... treatment that can permanently lighten discolored or naturally dark ... which involves a personalized treatment plan to address a patient’s ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Creative Recovery at Recovery Unplugged™—will be delivering a ... A Singer/Songwriter's Perspective on the Art of Healing ... Addiction Disorders (NCAD) and Behavioral Healthcare Executive Summit ... his name, Mr. Supa’s songs have been recorded ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2
... MA Brandeis University selected Jay and Maureen Neitz, the husband-and-wife ... gene therapy to treat vision disorders, as the inaugural recipients ... The award is funded by a $1 million endowment established ... ,75 and Susan K. Feigenbaum ,74, his wife. The endowment ...
... ... is a uniquely designed, extremely resilient, ‘two-in-one’ foam roller. This patented foam roller has ... of the most versatile foam rollers available. , ... Minneapolis, MN (PRWEB) December 17, 2009 -- The SMARTROLLER® ...
... accompanying lung infections , THURSDAY, Dec. 17 (HealthDay News) -- ... flu virus, and researchers say they,ve found a clue as ... illness appears to be a molecule called interleukin 17 (TH17), ... Researchers who analyzed levels of the molecule in swine-flu patients ...
... ... is pleased to announce its newly redesigned Web site: www.psanj.com . PSANJ is a ... as New York magazine and New Jersey Monthly. , ... New Brunswick, NJ (PRWEB) December 17, 2009 -- Plastic Surgery Arts ...
... ... Important ,for the R&D Informatics Industry, , ... Needham, MA (PRWEB) December 17, 2009 -- Cambridge Healthtech Institute ... 2nd Annual Adopting R&D Informatics Systems conference to be held on February 3-5, 2010 ...
... ... Byrne to lead the firm’s Interim Leadership division as senior vice president. A seasoned executive ... B. E. Smith today. , ... Lenexa, KS (Vocus) December 17, 2009 -- B. E. Smith recently hired Deirdre ...
Cached Medicine News:Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:OPTP Introduces the SMARTROLLER 2Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 2Health News:Plastic Surgery Arts of New Jersey (PSANJ) Launches New Web Site 3Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3
... Digital Multichannel, with it's streamlined ... of routine laboratory tasks. The ... features: Soft-touch tip ejection, Super ... (0.5-10ul models), Entire pipette autoclavable, ...
... wide variety of applications. • Whole pipette is ... freely rotated against the handle to work in ... angle towards the microtiter plate. • The special ... common pipette tips, and provides a firm, parallel ...
... to operate in a wide variety of applications. ... The manifold can be freely rotated against the ... always at an optimum angle towards the microtiter ... the use of most common pipette tips, and ...
... Features and Benefits: 1-8channel ... a new product number, created ... number. If showing no availability ... old Sigma-Aldrich number (Z37,174-2) or ...
Medicine Products: